For lab directors and molecular pathologists evaluating white-label interpretation. Decision-support, not diagnosis.
Pinned for lab directors and molecular pathologists: leave the test price war, ask five questions before you white-label, and see why the knowledge base is curated.
Every year the tests you run get cheaper to copy and harder to differentiate. The way out isn't a cheaper test — it's owning the layer above it: the interpretation.
The checklist a lab owner, hospital administrator or clinic director should put to any white-label genomics vendor — including us.
A hand-built 150,000-reference knowledge graph beats a scraped one — and in clinical genomics, that difference is measured in lives, not latency.
What to bring into a demo and technical scoping call - menu, LIMS webhook, brand files, sign-off path, and timing language already on the public site.
What "weeks not months" means when a diagnostic lab connects white-label interpretation into LIMS - sandbox first, webhook when the report is ready, timing as scoping input not SLA.
The compliance boundary lab buyers need before white-label interpretation - evidence trail, human sign-off, and why diagnosis language on a vendor deck is your risk.
Be the first to read new articles, case studies, and research from The Gene Box team.
